Diagnostics News and analysis on diagnostic technologies and applications. Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device. AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation The consensus guideline offers a two-tier categorization of alleles that are recommended for clinical CYP2D6 pharmacogenetic testing. C2i Genomics, NovogeneAIT Genomics Partner to Launch Cancer Detection Platform in Southeast Asia C2i's platform uses artificial intelligence pattern recognition and whole-genome analysis to detect minimal residual disease in blood samples from cancer patients. LetsGetChecked Closes $150M Funding Round The company will use the funding to launch care pathways, which will provide remote care for patients with chronic conditions. Enzo Biochem Q3 Revenues Nearly Double on Clinical Lab Testing Demand The recent quarter reflected growing demand for testing services and a steady improvement in sales of its products and services, the firm said. Jun 9, 2021 Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications Jun 9, 2021 New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection Jun 9, 2021 Hummingbird Bioscience, Novogene Partner to ID Cancer Patients With NRG1 Fusions in China Jun 9, 2021 Biocept, Cleared4 Partner to Provide COVID-19 Testing, Management Service Jun 9, 2021 Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic Jun 8, 2021 Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients Jun 8, 2021 ASCO Studies Highlight Systemic, Racial Inequities in Lung Cancer Biomarker Testing Premium Jun 8, 2021 Amazon, Diabetomics Get FDA Emergency Use Authorizations for Coronavirus Tests Jun 8, 2021 Oracle Makes Inroads in Genomic Cloud Computing Premium Jun 7, 2021 Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance Premium Jun 7, 2021 Bruker Receives CE-IVD Mark for Newly Launched SARS-CoV-2 PCR Test Jun 5, 2021 Myriad Genetics Recalibrates Breast Cancer PRS for All Ancestries in Anticipation of Broader Launch Premium Jun 4, 2021 New Single-Cell Prep Hack Pushes Limits of 10x Genomics' Chromium Towards 1M Nuclei Premium Jun 4, 2021 Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium Jun 4, 2021 Veracyte Expects HalioDx Acquisition to Drive International Market Growth Premium Jun 4, 2021 Akoya Biosciences, AstraZeneca Collaborate on Spatial Biomarker Profiling for Immuno-Oncology Jun 4, 2021 Veracyte Bladder Cancer Test Receives Medicare Coverage Jun 4, 2021 Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies Jun 3, 2021 Helix Raises $50M in Series C Financing Jun 3, 2021 Engine Biosciences Using CRISPR, Machine Learning to Build Drug Candidate Pipeline Premium Load More Breaking News Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test Alzheimer's Disease Meta-Analysis Identifies Novel Differentially Methylated Loci AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation Rockefeller Foundation Funds Global Pathogen Sequencing With $20M, Forms Collaborations C2i Genomics, NovogeneAIT Genomics Partner to Launch Cancer Detection Platform in Southeast Asia Illumina, Qiagen, Columbia University Near Settlement in Patent Infringement Case The Scan To Boost Vaccine Production in Africa BioNTech is planning to establish mRNA vaccine production facilities in Africa, the Financial Times reports. Sharing Required Retraction Watch reports that the Proceedings of the National Academy of Sciences has banned a researcher the journal for not sharing a strain of algae. Nature Papers Examine How Topologically Associating Domains Form, Develop Atlas of MicroRNA Expression In Nature this week: chromatin remodeling has role in topologically associating domain formation, and more. Delta Variant Spread CNBC reports the Delta variant now makes up more than 6 percent of SARS-CoV-2 infections in the US and 60 percent in the UK.